Regulation · Prescribing · Botulinum Toxin
Can You Prescribe Botox Remotely?
The UK Rules in 2026
What the GMC, NMC, GPhC and GDC expect before anyone prescribes botulinum toxin, what counts as “remote”, and how to set up your practice so it is compliant.
The short answer
No. In the UK you cannot prescribe Botox or any other botulinum toxin remotely. The GMC, NMC, GPhC and GDC all expect the prescriber to see and examine the patient in person before prescribing an injectable cosmetic medicine. A phone call, a video call or an online questionnaire is not enough.
Why the Rule Exists
Botulinum toxin is a prescription-only medicine. Whoever signs the prescription is professionally accountable for the decision to treat, even if someone else gives the injections. That decision depends on things you can only judge with the patient in front of you: facial anatomy and asymmetry, muscle strength, skin quality, contraindications, the patient’s expectations and, importantly, signs of body dysmorphic disorder or other vulnerability.
Cosmetic treatments are also elective. There is no clinical urgency that could justify skipping an examination, which is why the regulators treat them differently from, for example, a remote repeat prescription for a long-term condition.
What Each Regulator Says
GMC
Doctors
You must carry out a physical examination before prescribing non-surgical cosmetic medicines such as Botox, Dysport, Vistabel or other injectable cosmetic medicines, and you must not prescribe them remotely.
Good practice in prescribing and managing medicines and devices, paragraph 25.
NMC
Nurse and midwife prescribers
Since 1 June 2025, nurse and midwife prescribers must hold a face-to-face consultation with the patient before prescribing non-surgical cosmetic medicines. Remote prescribing for these treatments is no longer accepted.
NMC updated position on remote prescribing of non-surgical cosmetic medicines, 2025.
GPhC
Pharmacist prescribers
It is not appropriate to carry out a remote consultation for non-surgical cosmetic products; they should be administered only after a physical examination of the person.
GPhC guidance for pharmacist prescribers, section 4.3.
GDC
Dentists
Dentists who prescribe for cosmetic treatments are held to the same principle: assess the patient in person, prescribe only within your competence, and stay accountable for the treatment you prescribe.
GDC Standards for the Dental Team; the JCCP and CPSA also oppose remote prescribing for cosmetic medicines.
What Counts as “Remote”
Any arrangement where the prescriber has not personally seen and examined the patient before prescribing. In practice that includes:
- ✔A phone or video consultation, however detailed
- ✔An online form or questionnaire reviewed by a prescriber
- ✔Photos sent by WhatsApp, email or an app
- ✔A “prescriber on call” who signs prescriptions for patients they have never met
- ✔A prescription issued in advance for a clinic, a list of patients or a future event
If You Are Not a Prescriber
Many injectors are nurses, dentists or other professionals who do not prescribe. You can still give botulinum toxin, but only for a named patient whom a prescriber has examined in person and prescribed for. The prescriber remains accountable for that prescription, and you remain accountable for your own practice: if the arrangement is not compliant, both of you are exposed.
- ✔The prescriber has examined the patient face to face before prescribing
- ✔The prescription is for that named patient and that treatment
- ✔The consultation, consent and prescription are all documented
- ✔If the plan changes significantly, the patient is reassessed before more product is prescribed
- ✔Botox is never bought or held as stock “for whoever turns up”
Coming next: the licensing scheme
The government’s planned licensing scheme for England places Botox and fillers in the “amber” tier: non-healthcare practitioners would only be able to treat under a named, regulated healthcare professional. The scheme is not yet in force and has no start date, but the direction is clear. Prescriber oversight is becoming more important, not less.
A Quick Compliance Checklist
- ✔Every toxin patient is seen in person by the prescriber before the first prescription
- ✔Your booking system cannot confirm a toxin appointment without a prescriber consultation
- ✔Consultation notes record the examination, the indication and the consent discussion
- ✔You can show who prescribed for each patient, when and where
- ✔Your insurer knows your prescribing arrangement and covers it
Frequently Asked Questions
Can I do a video consultation first and examine the patient on the day?
Yes, a video call can be useful to answer questions and screen suitability, as long as the prescriber still examines the patient in person before the prescription is issued.
Does the prescriber have to be in the room when I inject?
The guidance focuses on the in-person assessment before prescribing. Who must be present during treatment depends on your setting, your insurer and, in future, the licensing scheme. Check your own arrangement in writing.
Is this rule the same for dermal fillers?
Most dermal fillers are medical devices, not prescription-only medicines, so they do not need a prescription. But the same standards of in-person assessment and consent apply to any injectable treatment.
What happens if I prescribe remotely?
It is a breach of your regulator’s standards and can lead to fitness to practise proceedings. It may also invalidate your indemnity cover.
Anatomy first. Judgement before technique. Safety always.
Learn to assess and treat safely
Our Botox courses and Level 7 Diploma teach patient assessment, consent and prescribing within the rules.
See Botox Level 1 →
Ask Us a Question
Related Courses
Please note
Last checked against the regulators’ published guidance: 20 October 2026. This article is general guidance for healthcare professionals, not legal advice. Regulators update their guidance, so always check the current version and your own regulator’s standards before changing how you practise.
Sources
